Hospital Value-Based Purchasing Program

Hospital Value-Based Purchasing Program
Name	Hospital Value-Based Purchasing Program
Established	2012
Administered by	Centers for Medicare & Medicaid Services
Type	Quality-based payment program
Region	United States

Hospital Value-Based Purchasing Program

The Hospital Value-Based Purchasing Program adjusts Medicare payments to acute care hospitals based on measured performance on clinical processes, patient experience, and outcomes. Originating from provisions in the Affordable Care Act and implemented by the Centers for Medicare & Medicaid Services, the program links fee-for-service Medicare reimbursement to quality metrics developed with stakeholders including the Agency for Healthcare Research and Quality, American Hospital Association, and specialty groups. It intersects with other federal initiatives such as the Hospital Readmissions Reduction Program and the Hospital-Acquired Condition Reduction Program to reshape incentives across U.S. Department of Health and Human Services portfolios.

Overview

The Program benchmarks performance across multiple domains to reward hospitals that meet or exceed national standards and to penalize underperforming institutions. Performance frameworks were influenced by earlier pay-for-performance pilots negotiated by the Center for Medicare and Medicaid Innovation and by recommendations from expert panels including the National Quality Forum and the Institute of Medicine. Implementation involved regulatory rulemaking at the Federal Register level and coordination with regional Medicare Administrative Contractors to adjust inpatient prospective payments under the Inpatient Prospective Payment System.

Program Structure and Measures

The Program organizes measures into domains such as Clinical Care, Safety, Person and Community Engagement, and Efficiency and Cost Reduction. Specific measures have included process measures used by the Joint Commission, outcome measures tracked by the Centers for Disease Control and Prevention, and the Hospital Consumer Assessment of Healthcare Providers and Systems survey administered by the Agency for Healthcare Research and Quality. Clinical process measures draw from specialty societies like the American College of Cardiology and the American College of Surgeons; infection and safety metrics reference data from the National Healthcare Safety Network of the Centers for Disease Control and Prevention. Cost measures have been developed using standardized claims methodologies similar to those used by the Office of the Actuary (CMS) and the Medicare Payment Advisory Commission.

Payment Methodology

Adjustments are funded through a small withhold of base operating payments under the Inpatient Prospective Payment System, pooled and redistributed based on hospital performance scores. CMS calculates Total Performance Scores using weighting rules published in annual rulemaking by the Centers for Medicare & Medicaid Services and informed by actuarial analyses from the Office of the Actuary (CMS). Financial adjustments affect payments under Medicare Part A for eligible acute care hospitals and interact with payment policies from the Centers for Disease Control and Prevention guidance and the Social Security Act provisions that codify Medicare payment authorities.

Performance Measurement and Reporting

Hospitals submit clinical data to CMS and to quality registries such as the National Quality Registry Network and specialty registries maintained by the American College of Cardiology and the Society of Thoracic Surgeons. Patient experience scores derive from the Hospital Consumer Assessment of Healthcare Providers and Systems instrument administered by vendors certified by the Agency for Healthcare Research and Quality. CMS publishes performance results in public reporting platforms and on the Hospital Compare tool, enabling comparative analyses by researchers at institutions like Harvard School of Public Health, Johns Hopkins University, and the Kaiser Family Foundation.

Impact and Outcomes

Empirical evaluations by academics at Yale University, University of Michigan, Stanford University, and policy analysts at the Urban Institute and the Brookings Institution have produced mixed evidence on mortality, readmissions, and costs. Some studies reported modest improvements in process adherence and patient experience tracked by the National Quality Forum, while others found limited effects on outcome measures reported by the Agency for Healthcare Research and Quality or heterogeneous impacts across hospital types such as safety-net hospitals represented by the National Association of Public Hospitals and Health Systems.

Criticisms and Controversies

Critics from the American Hospital Association, safety-net advocates, and researchers at the Commonwealth Fund and RAND Corporation have raised concerns about risk adjustment, unintended incentives, and disproportionate penalties for hospitals serving complex populations. Legal challenges and policy debates have involved stakeholders such as the Association of American Medical Colleges and state hospital associations during rulemaking comment periods in the Federal Register. Concerns include measure selection influenced by specialty societies like the American College of Cardiology, the burden of data reporting noted by the Office of Inspector General (HHS), and equity issues highlighted by civil rights groups and researchers at the Health Affairs journal.

Implementation and Policy History

The Program’s statutory basis was enacted in the Patient Protection and Affordable Care Act with implementation phased by annual CMS rules beginning in the early 2010s. Major policy milestones included the initial scoring methodology, subsequent incorporation of efficiency measures recommended by the Medicare Payment Advisory Commission, and iterative changes after input from the National Quality Forum and stakeholder comment letters from organizations such as the American Hospital Association and Association of American Medical Colleges. Ongoing modifications reflect evidence reviews by academic centers like Harvard Medical School and policy briefs from the Kaiser Family Foundation, with future revisions shaped by Congressional hearings before the United States House Committee on Ways and Means and the United States Senate Committee on Finance.

Category:Medicare